封面
市場調查報告書
商品編碼
1676167

全球口服補液鹽 (ORS) 市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Oral Rehydration Solution (ORS) Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: | 出版商: Value Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

全球口服補液鹽 (ORS) 市場規模預計將從 2024 年的 32.8 億美元成長到 2033 年的 77.1 億美元,在 2026 年至 2033 年的預測期內呈現 9.97% 的強勁年複合成長率(CAGR)。

隨著對有效補液療法的需求不斷增加,口服補液鹽(ORS)市場有望大幅成長,尤其是在腹瀉和其他胃腸道疾病導致脫水高發的地區。 ORS 是一種簡單且經濟有效的解決方案,有助於補充流失的液體和電解質,使其成為公共衛生計劃的重要組成部分。人們越來越意識到補水的重要性以及 ORS 在預防嚴重脫水方面的有效性,正在推動全球對這些解決方案的需求。

技術進步在塑造 ORS 市場的未來方面發揮著至關重要的作用。配方科學的創新,包括開發調味和即用 ORS 產品,正在提高患者(尤其是兒童)的接受度和易用性。此外,包裝和分發方法的進步也正在改善醫療資源匱乏地區獲得 ORS 的機會。隨著製造商持續投資於研發,ORS 市場可能會在各種醫療保健環境中得到更廣泛的應用,包括醫院、診所和社區健康計畫。

此外,對預防性醫療保健和教育的日益重視正在影響 ORS 市場的成長軌跡。隨著醫療保健提供者和組織注重提高人們對脫水和 ORS 益處的認知,對教育資源和社區外展計劃的需求日益增加。這一趨勢正在推動製造商、醫療保健專業人員和公共衛生機構之間的合作,以製定使個人和家庭能夠有效管理補水的措施。隨著市場的不斷發展,技術、教育和社區參與的融合將成為成功的關鍵驅動力。

我們的報告經過精心製作,為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分,以確保徹底了解市場格局:

市場概覽:市場的詳細介紹,包括定義、分類和行業現狀概述。

市場動態:深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析:根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局:對主要市場參與者的全面評估,包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測:根據歷史資料和當前市場狀況,預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析:評估不同地理區域的市場表現,確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會:識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章:前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:口服補液鹽 (ORS) 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析:按產品類型
    • 市場吸引力分析:按應用
    • 按配銷通路進行市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析:按地區

第4章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球口服補液鹽 (ORS) 市場分析:依產品類型

  • 概覽:依產品類型
  • 歷史與預測資料分析:按產品類型
  • 平板電腦
  • 粉末
  • 解決方案

第 6 章:全球口服補液鹽 (ORS) 市場分析:依應用

  • 概述:按應用
  • 歷史和預測數據分析:按應用
  • 醫院
  • 診所
  • 居家護理
  • 其他

第 7 章:全球口服補液鹽 (ORS) 市場分析:依通路

  • 按配銷通路概覽
  • 按配銷通路進行的歷史和預測資料分析
  • 線上商店
  • 藥局
  • 超市/大賣場
  • 專賣店
  • 其他

第 8 章:全球口服補液鹽 (ORS) 市場分析:依最終用戶

  • 最終用戶概覽
  • 最終用戶的歷史和預測數據分析
  • 嬰兒
  • 孩子們
  • 成年人
  • 老年

第 9 章:全球口服補液鹽 (ORS) 市場分析:按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 10 章:口服補液鹽 (ORS) 公司的競爭格局

  • 口服補液鹽(ORS)市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第 11 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Johnson & Johnson
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sanofi
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pfizer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abbott Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GlaxoSmithKline Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bayer AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck & Co. Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cipla Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sun Pharmaceutical Industries Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Daiichi Sankyo Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Reckitt Benckiser Group Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Nestlé SA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Baxter International Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中,財務細節和最新發展取決於可用性,對於私人公司,可能不予涵蓋

Product Code: VMR11219611

Global Oral Rehydration Solution (ORS) Market size is anticipated to grow from USD 3.28 Billion in 2024 to USD 7.71 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.97% during the forecast period of 2026 to 2033.

The Oral Rehydration Solution (ORS) Market is poised for significant growth as the demand for effective rehydration therapies increases, particularly in regions with high incidences of dehydration due to diarrhea and other gastrointestinal disorders. ORS is a simple and cost-effective solution that helps replenish lost fluids and electrolytes, making it a critical component of public health initiatives. The rising awareness of the importance of hydration and the effectiveness of ORS in preventing severe dehydration is driving the demand for these solutions globally.

Technological advancements are playing a crucial role in shaping the future of the ORS market. Innovations in formulation science, including the development of flavored and ready-to-use ORS products, are enhancing the acceptability and ease of use for patients, particularly children. Additionally, advancements in packaging and distribution methods are improving access to ORS in underserved areas. As manufacturers continue to invest in research and development, the ORS market is likely to see increased adoption across various healthcare settings, including hospitals, clinics, and community health programs.

Moreover, the growing emphasis on preventive healthcare and education is influencing the ORS market's growth trajectory. As healthcare providers and organizations focus on promoting awareness of dehydration and the benefits of ORS, there is a rising demand for educational resources and community outreach programs. This trend is driving collaboration between manufacturers, healthcare professionals, and public health agencies to develop initiatives that empower individuals and families to manage hydration effectively. As the market continues to evolve, the integration of technology, education, and community engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Tablets
  • Powders
  • Solutions

By Application

  • Hospitals
  • Clinics
  • Home Care
  • Others

By Distribution Channel

  • Online Stores
  • Pharmacies
  • Supermarkets/Hypermarkets
  • Specialty Stores
  • Others

By End-User

  • Infants
  • Children
  • Adults
  • Elderly
  • COMPANIES PROFILED
  • Johnson & Johnson
  • Sanofi
  • Pfizer Inc.
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Bayer AG
  • Novartis AG
  • Merck & Co. Inc.
  • F. Hoffmann-La Roche Ltd
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Daiichi Sankyo Company
  • Limited
  • Reckitt Benckiser Group plc
  • Nestle S.A.
  • Baxter International Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ORAL REHYDRATION SOLUTION (ORS) INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Tablets Historic and Forecast Sales By Regions
  • 5.4. Powders Historic and Forecast Sales By Regions
  • 5.5. Solutions Historic and Forecast Sales By Regions

6. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Clinics Historic and Forecast Sales By Regions
  • 6.5. Home Care Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Online Stores Historic and Forecast Sales By Regions
  • 7.4. Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Supermarkets/Hypermarkets Historic and Forecast Sales By Regions
  • 7.6. Specialty Stores Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Infants Historic and Forecast Sales By Regions
  • 8.4. Children Historic and Forecast Sales By Regions
  • 8.5. Adults Historic and Forecast Sales By Regions
  • 8.6. Elderly Historic and Forecast Sales By Regions

9. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ORAL REHYDRATION SOLUTION (ORS) COMPANIES

  • 10.1. Oral Rehydration Solution (ORS) Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Johnson & Johnson
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Sanofi
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Pfizer Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Abbott Laboratories
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. GlaxoSmithKline Plc
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Bayer AG
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Novartis AG
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Merck & Co. Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. F. Hoffmann-La Roche Ltd
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Cipla Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Sun Pharmaceutical Industries Ltd.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Daiichi Sankyo Company
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Limited
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Reckitt Benckiser Group Plc
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Nestlé S.A.
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Baxter International Inc
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Powders Market Sales By Geography (USD MN)
  • Solutions Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Care Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Online Stores Market Sales By Geography (USD MN)
  • Pharmacies Market Sales By Geography (USD MN)
  • Supermarkets/Hypermarkets Market Sales By Geography (USD MN)
  • Specialty Stores Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Infants Market Sales By Geography (USD MN)
  • Children Market Sales By Geography (USD MN)
  • Adults Market Sales By Geography (USD MN)
  • Elderly Market Sales By Geography (USD MN)
  • Global Oral Rehydration Solution (ORS) Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Rehydration Solution (ORS) Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Rehydration Solution (ORS) Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Tablets Market Sales By Geography (USD MN)
  • Powders Market Sales By Geography (USD MN)
  • Solutions Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Care Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Online Stores Market Sales By Geography (USD MN)
  • Pharmacies Market Sales By Geography (USD MN)
  • Supermarkets/Hypermarkets Market Sales By Geography (USD MN)
  • Specialty Stores Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Infants Market Sales By Geography (USD MN)
  • Children Market Sales By Geography (USD MN)
  • Adults Market Sales By Geography (USD MN)
  • Elderly Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.